137 related articles for article (PubMed ID: 3585664)
1. Serial determination of serum neuron-specific enolase in patients with neuroblastoma and other pediatric tumors.
Tsuchida Y; Honna T; Iwanaka T; Saeki M; Taguchi N; Kaneko T; Koide R; Tsunematsu Y; Shimizu K; Makino S
J Pediatr Surg; 1987 May; 22(5):419-24. PubMed ID: 3585664
[TBL] [Abstract][Full Text] [Related]
2. Neuron-specific enolase in neuroblastoma and other pediatric tumors: a comparative nude mouse and clinical investigation.
Tsuchida Y; Yokota S; Bessho F; Yokomori K; Makino S; Saito S
Tumour Biol; 1985; 6(1):67-73. PubMed ID: 4023563
[TBL] [Abstract][Full Text] [Related]
3. Serum neuron-specific enolase as a marker useful for monitoring the effectiveness of therapy in patients with neuroblastoma--as compared with urinary catecholamine metabolites.
Hashimoto K; Gotoh Y; Tada K
Tohoku J Exp Med; 1986 May; 149(1):25-30. PubMed ID: 3738914
[TBL] [Abstract][Full Text] [Related]
4. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course.
Zeltzer PM; Marangos PJ; Evans AE; Schneider SL
Cancer; 1986 Mar; 57(6):1230-4. PubMed ID: 3002599
[TBL] [Abstract][Full Text] [Related]
5. High levels of immunoreactive nervous system-specific enolase in sera of patients with neuroblastoma.
Ishiguro Y; Kato K; Shimizu A; Ito T; Nagaya M
Clin Chim Acta; 1982 May; 121(2):173-80. PubMed ID: 7046994
[TBL] [Abstract][Full Text] [Related]
6. [The value of neuron specific enolase (NSE) in patients with brain tumors].
Taomoto K; Kokunai T; Okuda T; Tamaki N; Matsumoto S; Hashimoto N
No To Shinkei; 1987 Feb; 39(2):169-73. PubMed ID: 3828153
[TBL] [Abstract][Full Text] [Related]
7. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group.
Zeltzer PM; Marangos PJ; Parma AM; Sather H; Dalton A; Hammond D; Siegel SE; Seeger RC
Lancet; 1983 Aug; 2(8346):361-3. PubMed ID: 6135871
[TBL] [Abstract][Full Text] [Related]
8. Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma.
Berthold F; Engelhardt-Fahrner U; Schneider A; Schumacher R; Zieschang J
In Vivo; 1991; 5(3):245-7. PubMed ID: 1893081
[TBL] [Abstract][Full Text] [Related]
9. Neuron-specific enolase evaluation in patients with neuroblastoma.
Massaron S; Seregni E; Luksch R; Casanova M; Botti C; Ferrari L; Martinetti A; Molteni SN; Bellani FF; Bombardieri E
Tumour Biol; 1998; 19(4):261-8. PubMed ID: 9679736
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunoassay development for human neuron-specific enolase: with some clinical results in lung cancers and neuroblastoma.
Notomi T; Morikawa J; Kato K; Tsuchida Y; Ohsawa R
Tumour Biol; 1985; 6(1):57-66. PubMed ID: 3895369
[TBL] [Abstract][Full Text] [Related]
11. Serum neuron-specific/nonneuronal enolase ratio in the diagnosis of neuroblastomas.
Viallard JL; Tiget F; Hartmann O; Lemerle J; Demeocq F; Malpuech G; Dastugue B
Cancer; 1988 Dec; 62(12):2546-53. PubMed ID: 3191453
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the relationship between MYCN gene and serum NSE and urinary VMA levels and neuroblastoma pathological features and prognosis.
Zhang H; He X; Miao Q; Li L; Song J; Jiang X
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):134-139. PubMed ID: 38678619
[TBL] [Abstract][Full Text] [Related]
13. Serum neuron-specific enolase in children's cancer.
Cooper EH; Pritchard J; Bailey CC; Ninane J
Br J Cancer; 1987 Jul; 56(1):65-7. PubMed ID: 3476145
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of neural isozymes by human medulloblastomas and gliomas and neuroectodermal cell lines.
Zeltzer PM; Schneider SL; Marangos PJ; Zweig MH
J Natl Cancer Inst; 1986 Sep; 77(3):625-31. PubMed ID: 3462406
[TBL] [Abstract][Full Text] [Related]
15. Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.
Georgantzi K; Sköldenberg EG; Stridsberg M; Kogner P; Jakobson Å; Janson ET; Christofferson RHB
Pediatr Hematol Oncol; 2018 Mar; 35(2):156-165. PubMed ID: 29737901
[TBL] [Abstract][Full Text] [Related]
16. Serum neuron-specific enolase levels in preterm and term newborns and in infants 1-3 months of age.
Abbasoglu A; Sarialioglu F; Yazici N; Bayraktar N; Haberal A; Erbay A
Pediatr Neonatol; 2015 Apr; 56(2):114-9. PubMed ID: 25315754
[TBL] [Abstract][Full Text] [Related]
17. [The use of neuron specific enolase in the prognosis and followup of neuroblastoma in children. Results of a retrospective series of 21 patients].
Abdennebi M; Boussen H; Harzallah L; Daldoul O; Ghanem A; Gamoudi A; Ben Slimene F; Rahal K; el May A; Ben Ayed F; Guemira F
Tunis Med; 2000 Feb; 78(2):106-8. PubMed ID: 10894045
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum neuron-specific enolase in patients with malignant pheochromocytoma.
Oishi S; Sato T
Cancer; 1988 Mar; 61(6):1167-70. PubMed ID: 3342373
[TBL] [Abstract][Full Text] [Related]
19. Tumour markers are poor predictors for relapse or progression in neuroblastoma.
Simon T; Hero B; Hunneman DH; Berthold F
Eur J Cancer; 2003 Sep; 39(13):1899-903. PubMed ID: 12932669
[TBL] [Abstract][Full Text] [Related]
20. Urine neuron-specific enolase and its clinical implication in patients with neuroblastoma.
Gotoh Y; Hashimoto K; Tada K
Tohoku J Exp Med; 1986 May; 149(1):67-72. PubMed ID: 3738918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
